Differentiating Biopharmaceutical Raw Materials Using Spatially Offset Raman Spectroscopy

Date:

Ensuring the quality and authenticity of biopharmaceutical raw materials is critical for maintaining safe and efficient production processes. Traditional identification methods often require container opening, sampling, and laboratory testing, creating delays, increasing contamination risks, and adding operational complexity.

This application note explores how Spatially Offset Raman Spectroscopy (SORS) enables rapid, non-destructive identification of biopharmaceutical raw materials directly through transparent and opaque containers. Using the handheld Agilent Vaya Raman spectrometer, manufacturers can accurately differentiate buffers, amino acids, surfactants, cell culture media, and inorganic salts in seconds—without sampling or compromising material integrity.

The study demonstrates how SORS technology streamlines incoming material verification, reduces warehouse processing time, preserves sterility, and supports regulatory compliance by providing fast and reliable raw material identification. By eliminating traditional sampling requirements, biopharmaceutical organizations can improve operational efficiency while strengthening quality control across the supply chain.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

Cyberrisico’s zetten bedrijfscontinuïteit het meest onder druk

AuthorTechzine RedactieMaar liefst 48 procent van de bedrijven verwacht...

Beyond the Device: Cyber Asset Intelligence for the AI Agent Explosion

As AI agents proliferate across the enterprise, they're creating...

Optimize cloud efficiency with Red Hat Enterprise Linux for AWS

Organizations need to run their existing systems while preparing...

Effectively manage AWS cloud environments with Red Hat Lightspeed

Enterprises depend on the cloud to store data and...